P392-2057 Screening compound: 2-[(1-{[(3-ethoxypropyl)amino]carbonyl}tetrahydro-1H-pyrrol-3-yl)oxy]-N~3~,N~3~-dimethylnicotinamide

P392-2057 Screening compound: 2-[(1-{[(3-ethoxypropyl)amino]carbonyl}tetrahydro-1H-pyrrol-3-yl)oxy]-N~3~,N~3~-dimethylnicotinamide
P392-2057 Screening compound: 2-[(1-{[(3-ethoxypropyl)amino]carbonyl}tetrahydro-1H-pyrrol-3-yl)oxy]-N~3~,N~3~-dimethylnicotinamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P392-2057
2-[(1-{[(3-ethoxypropyl)amino]carbonyl}tetrahydro-1H-pyrrol-3-yl)oxy]-N~3~,N~3~-dimethylnicotinamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P392-2057

Molecular Formula

C18H28N4O4 (C18 H28 N4 O4)

Compound Name

2-[(1-{[(3-ethoxypropyl)amino]carbonyl}tetrahydro-1H-pyrrol-3-yl)oxy]-N~3~,N~3~-dimethylnicotinamide

IUPAC name

2-({1-[(3-ethoxypropyl)carbamoyl]pyrrolidin-3-yl}oxy)-NN-dimethylpyridine-3-carboxamide

SMILES

CCOCCCNC(N(CC1)CC1Oc1ncccc1C(N(C)C)=O)=O

InChI

InChI=1S/C18H28N4O4/c1-4-25-12-6-10-20-18(24)22-11-8-14(13-22)26-16-15(7-5-9-19-16)17(23)21(2)3/h5,7,9,14H,4,6,8,10-13H2,1-3H3,(H,20,24)/t14-/m1/s1

InChI Key

LZTBVGJIPZBXEC-CQSZACIVSA-N

MDL Number (MFCD)

MFCD28999185

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

364.44

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

0.450

Distribution Coefficient, logD

0.450

Water Solubility, LogSw

-1.94

Polar Surface Area

67.487

Acid Dissociation Constant (pKa)

17.02

Base Dissociation Constant (pKb)

1.02

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

61.11

P392-2057 in Drug Discovery

Included in Screening Libraries

Ligand-Gated Ion Channels Library (3887 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Eye
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Ion Channels
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • Epigenetic
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with P392-2057 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P392-2057?
Check Price and Availability of P392-2057, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P392-2057 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P392-2057
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P392-2057
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P392-2057 available by request